Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Diurnal and Nocturnal Effect of Simbrinza and Timolol on Intraocular Pressure and Ocular Perfusion Pressure

NCT02165631 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.

NCT NCT02165631
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02165631 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Diurnal and Nocturnal Effect of Simbrinza and Timolol on Intraocular Pressure and Ocular Perfusion Pressure
Lead sponsor
University of Colorado, Denver
Phase
Observational
Overall status
Completed
Start date
August 31, 2014
Completion date
March 31, 2016
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ocular hypertension, open angle glaucoma, pigment dispersion syndrome, pseudoexfoliation glaucoma